We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
Verve Therapeutics Inc is a genetic medicines company pioneering a new approach to the care of cardiovascular disease, transforming treatment from chronic management to single-course gene editing medicines. The company's initial two programs target PCSK9 and ANGPTL3, genes that have been extensively... Verve Therapeutics Inc is a genetic medicines company pioneering a new approach to the care of cardiovascular disease, transforming treatment from chronic management to single-course gene editing medicines. The company's initial two programs target PCSK9 and ANGPTL3, genes that have been extensively validated as targets for lowering blood lipids such as low-density lipoprotein cholesterol, a root cause of cardiovascular disease. The company views its operations as and manages its business in one operating segment operating exclusively in the United States. Show more
Heart-1 clinical trial demonstrated LDL-C reduction of up to 73% at 0.45 mg/kg of VERVE-101 Company to pause enrollment in Heart-1 clinical trial following asymptomatic Grade 3 transient ALT...
BOSTON, March 28, 2024 (GLOBE NEWSWIRE) -- Verve Therapeutics, a clinical-stage biotechnology company pioneering a new approach to the care of cardiovascular disease with single-course gene...
BOSTON, March 01, 2024 (GLOBE NEWSWIRE) -- Verve Therapeutics, a clinical-stage biotechnology company pioneering a new approach to the care of cardiovascular disease with single-course gene...
Three Clinical Stage Programs Targeting PCSK9 and ANGPTL3 Expected in 2024 Announced First Human Proof-of-Concept Data for In Vivo Base Editing from Ongoing Heart-1 Phase 1b Clinical Trial of...
| Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -1.46 | -18.3186951066 | 7.97 | 8.02 | 6.42 | 1129444 | 7.090018 | CS |
| 4 | -6.7 | -50.7191521575 | 13.21 | 13.63 | 6.42 | 1580883 | 8.75425758 | CS |
| 12 | -5.54 | -45.9751037344 | 12.05 | 19.34 | 6.42 | 1317523 | 11.84722185 | CS |
| 26 | -4.49 | -40.8181818182 | 11 | 20.12 | 6.42 | 1519120 | 12.09260331 | CS |
| 52 | -9.15 | -58.4291187739 | 15.66 | 21.4199 | 6.42 | 1079442 | 13.25151948 | CS |
| 156 | -23.49 | -78.3 | 30 | 78 | 6.42 | 863947 | 22.02281836 | CS |
| 260 | -23.49 | -78.3 | 30 | 78 | 6.42 | 863947 | 22.02281836 | CS |
Monksdream
3 days ago
Firestorm22
2 weeks ago
Monksdream
3 weeks ago
fink
2 months ago
Terpi
5 months ago
Monksdream
6 months ago
TheFinalCD
1 year ago
crudeoil24
2 years ago
crudeoil24
2 years ago
crudeoil24
2 years ago
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
